ImmuPharma Share Forecast, Price & News

ImmuPharma (LON:IMM) Frequently Asked Questions

How has ImmuPharma's stock price been impacted by Coronavirus?

ImmuPharma's stock was trading at GBX 10.76 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, IMM shares have decreased by 49.5% and is now trading at GBX 5.43.
View which stocks have been most impacted by COVID-19.

How were ImmuPharma's earnings last quarter?

ImmuPharma plc (LON:IMM) released its quarterly earnings data on Wednesday, September, 30th. The company reported ($1.69) EPS for the quarter.
View ImmuPharma's earnings history.

Who are ImmuPharma's key executives?

ImmuPharma's management team includes the following people:

• Mr. Dimitri F. Dimitriou, Co-Founder, CEO & Director (Age 59, Pay $320.3k)
• Dr. D. Robert Henri Zimmer, Co-Founder, Pres, Chief Scientific Officer & Director (Age 73, Pay $356.39k)
• Mr. Peter Hein, Interim Chief Financial Officer (Age 64)
• Dr. Timothy Gary Franklin M.B.A., Ph.D., Chief Operating Officer
• Ms. Lisa Baderoon, Head of Investor Relations
• Dr. Jean-Marie Geiger PharmD, MD, Head of Clinical Devel.
• Ms. Ewa Flynn M.A., Financial Controller & Company Sec.

Who are some of ImmuPharma's key competitors?

Some companies that are related to ImmuPharma include ReNeuron Group (RENE), Asterias Biotherapeutics (AST), Emerald Health Therapeutics (EMH), Devonian Health Group (GSD), Sirona Biochem (SBM), Ceapro (CZO), Oxford BioDynamics (OBD), Horizon Discovery Group plc (HZD.L) (HZD), Tissue Regenix Group (TRX), OptiBiotix Health (OPTI), Antibe Therapeutics (ATE), Rua Life Sciences (RUA), Fusion Antibodies (FAB), Collagen Solutions plc (COS.L) (COS) and Ensysce Biosciences (ENSC).
View all of IMM's competitors.

What other stocks do shareholders of ImmuPharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ImmuPharma investors own include Castleton Technology (CTP), MOTIF BIO PLC/S (MTFB), Aminex (AEX), Legendary Investments (LEG), Richland Resources Ltd (RLD.L) (RLD), Sound Energy (SOU), Thor Mining (THR), Acacia Mining (ACA), ALU (ALU) and (DARA) (DARA).

What is ImmuPharma's stock symbol?

ImmuPharma trades on the London Stock Exchange (LON) under the ticker symbol "IMM."

How do I buy shares of ImmuPharma?

Shares of IMM and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is ImmuPharma's stock price today?

One share of IMM stock can currently be purchased for approximately GBX 5.43.

How much money does ImmuPharma make?

ImmuPharma has a market capitalization of £13.59 million and generates £87.99 thousand in revenue each year.

How many employees does ImmuPharma have?

ImmuPharma employs 18 workers across the globe.

What is ImmuPharma's official website?

The official website for ImmuPharma is www.immupharma.org.

Where are ImmuPharma's headquarters?

ImmuPharma is headquartered at 50 Broadway, LONDON, SW1H 0BL, United Kingdom.

How can I contact ImmuPharma?

ImmuPharma's mailing address is 50 Broadway, LONDON, SW1H 0BL, United Kingdom. The company can be reached via phone at +44-20-71524080.